A clinical study to compare the dental plaque removal efficacy of a new electric toothbrush compared to a regular manual toothbrush
| ISRCTN | ISRCTN28649560 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN28649560 |
| Secondary identifying numbers | Clinical protocol number 2019135 |
- Submission date
- 17/08/2020
- Registration date
- 21/08/2020
- Last edited
- 18/08/2020
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Oral Health
Plain English Summary
Background and study aims
A regular daily program of oral hygiene is vital for oral health. Accumulation of plaque bacteria rapidly leads to gingivitis (inflammation of the gums). Ineffective plaque control by toothbrushing can result from poor technique, short brushing duration, lack of motivation, or insufficient toothbrush performance.
One approach to improve daily oral hygiene has been the development of the electric toothbrush. Electric toothbrushes with oscillating/rotating technology have consistently shown to be highly effective in both plaque removal and control of gingivitis, without compromising safety to oral tissues. New electric toothbrushes are under continuous review for improvement.
Digital Plaque Imaging Analysis (DPIA) is a method of plaque measurement that allows simultaneous assessment of plaque regrowth overnight and during the day, and provides data on hygiene efficiency from evaluations after brushing.
The aim of this study is to assess the overnight and afternoon plaque regrowth rate during a 1-week period of brushing with a newly developed Oral-B electric toothbrush compared to a reference manual toothbrush.
Who can participate?
Generally healthy volunteers aged 18 or older with a sufficient amount of plaque
What does the study involve?
Participants are randomly allocated to a treatment sequence of the two toothbrushes. Participants brush for 8 days per study period at home twice daily with their assigned toothbrush: two periods with the electric brush, two periods with the manual brush. Participants brush the whole time with a standard anti-cavity toothpaste. During each period they come on site on days 1,3, and 8 for a morning pre-brush picture and a 5-hours post-brushing picture.
What are the possible benefits and risks of participating?
Participation helps with the development of products that aim to prove oral health. Possible risks of using a normal toothbrush are not expected.
Where is the study run from?
Universitätsmedizin der Johannes Gutenberg Universität Mainz (Mainz University Medical School) (Germany)
When is the study starting and how long is it expected to run for?
August 2020 to December 2020
Who is funding the study?
Procter & Gamble (USA)
Who is the main contact?
Dr Christina Erbe
erbe@uni-mainz.de
Contact information
Scientific
Universitätsmedizin der Johannes Gutenberg Universität Mainz
Klinik für Zahn- Mund- und Kieferkrankheiten
Poliklinik für Kieferorthopädie
Augustusplatz 2
Mainz
55131
Germany
| Phone | +49 (0)6131 173024 |
|---|---|
| erbe@uni-mainz.de |
Study information
| Study design | Single-center two-treatment randomized four-period cross-over trial |
|---|---|
| Primary study design | Interventional |
| Secondary study design | Randomised cross over trial |
| Study setting(s) | Home |
| Study type | Prevention |
| Participant information sheet | Not available in web format, please use the contact details to request a participant information sheet |
| Scientific title | Clinical study to compare the plaque removal efficacy of a new power toothbrush with a reference manual brush by means of digital plaque imaging analysis |
| Study hypothesis | The central aim of this clinical investigation is to assess whether brushing with an electric toothbrush would provide additional plaque removal efficacy beyond that achieved with a standard manual toothbrush. |
| Ethics approval(s) | Approved 08/04/2019, Ethics Committee of the State Medical Association Rhineland Palatinate (Landesärztekammer Rheinland-Pfalz, Postfach 2926, 55019 Mainz; +49 (0)6131 28822-63/-64/-65/-67; ethic-kommission@laek-rlp.de), ref: 2020-14928 |
| Condition | Dental caries prevention |
| Intervention | The computer-generated randomization of the test products is created in cooperation with a statistician (Dr Julie Grender) from P&G. Participants are randomly allocated to a treatment sequence of the two toothbrushes. Participants brush for 8 days per study period at home twice daily (morning and evening) for 2 min according to the manufacturer’s use instructions with their assigned toothbrush: two periods with the electric brush, two periods with the manual brush (four periods in total, each period consists of 8 days). Participants brush the whole time with standard anti-cavity toothpaste. Participants will be requested to use exclusively their assigned products at home for the duration of each study period. Each treatment period of this cross-over study will be 8 days in duration (Tuesday through Tuesday) and will consist of Day 1, Day 3 and Day 8 study visits. Each study visit will consist of a pre-brushing DPIA measurement followed by a supervised on-site product use (this brushing will be considered one of the two daily brushings) and a second DPIA measurement taken approximately 5 hours post-brushing. There will be 6 days of washout between treatment periods (Wednesday through Monday) during which participants will use a manual toothbrush and NaF toothpaste as acclimation product. This study procedures will be repeated until participants have completed four treatment periods using their randomly assigned treatment sequence. The plaque is assessed using a digital photo of the front teeth after staining with fluorescein. The test person places her/his chin in a chin rest and uses two plastic retractors to open the oral cavity sufficiently so that the entire front tooth area is clearly visible. The upper and lower incisors are positioned edge to edge and opened slightly. The plaque is made visible with the help of blue light. The digital images are then masked and analyzed using a validated computer image analysis program. |
| Intervention type | Device |
| Pharmaceutical study type(s) | |
| Phase | Not Applicable |
| Drug / device / biological / vaccine name(s) | |
| Primary outcome measure | Differences in afternoon plaque (5 hours post-brushing) measured by DPIA score (digital plaque imaging analysis) across the 8 days of treatment |
| Secondary outcome measures | Morning pre-brushing plaque coverage measured by DPIA score (digital plaque imaging analysis) analysed separately for days 3 and 8 to determine treatment differences |
| Overall study start date | 20/08/2020 |
| Overall study end date | 31/12/2020 |
Eligibility
| Participant type(s) | Healthy volunteer |
|---|---|
| Age group | Adult |
| Lower age limit | 18 Years |
| Sex | Both |
| Target number of participants | 40 to complete the study |
| Total final enrolment | 46 |
| Participant inclusion criteria | 1. Be at least 18 years of age 2. Provide written informed consent prior to participation and be given a signed copy of the informed consent form 3. Be in general good health as determined by the Investigator/designee based on a review/update of their medical history 4. Have sufficient amount of plaque (estimated 10% coverage on buccal sites of front teeth after 24 hours build-up as estimated by DPIA operator) 5. Possess a minimum of 10 natural anterior teeth with facial scorable surfaces (Not including teeth with crowns, excessive facial restorations or severe staining from tetracycline, fluorosis or hypocalcification) 6. Agree not to participate in any other oral care study for the duration of this study 7. Agree to return for scheduled visits and follow the study procedures 8. Agree to refrain from use of any non-study oral hygiene products (including prescription rinses) for the duration of the study 9. Agree to delay any elective dentistry, including dental prophylaxis, until the completion of the study and to report any non-study dentistry received during the course of this study 10. Agree to refrain from using dental floss during the treatment periods of this study (Tuesday through Tuesday) 11. Agree to refrain from all oral hygiene procedures for approximately 24 hours prior to all subsequent morning visits 12. Agree to refrain from all oral hygiene procedures between all subsequent morning on-site brushings and the afternoon imaging visits 13. Agree to refrain from eating, drinking*, chewing gum and using tobacco for 2 hours prior to their morning appointments and 1 hour prior to their afternoon appointments? *The only exception being allowed small sips of water up until 1 hour prior to their morning appointments |
| Participant exclusion criteria | 1. Hypersensitivity to dyes 2. Any caries lesions requiring restorative treatment 3. Active treatment for periodontitis 4. Fixed facial or lingual orthodontic appliances 5. Self-reported pregnancy or lactation 6. Performing any oral hygiene the morning of or the evening prior to their Visit 1 study visit 7. Having eaten, drank, used tobacco or chewed gum for at least 2 hours prior to their Baseline visit (Small sips of water will be allowed up to 45 minutes prior to the visit) 8. Any diseases or condition that could be expected to interfere with examination procedures or with the subject safely competing the study (including allergies to dyes) 9. Inability to undergo study procedures 10. Using an antibiotic or a chlorhexidine mouth rinse any time within 2 weeks prior to this visit 11. Calculus on the facial surface of their teeth (per operator discretion) |
| Recruitment start date | 20/07/2020 |
| Recruitment end date | 10/08/2020 |
Locations
Countries of recruitment
- Germany
Study participating centre
Mainz
55131
Germany
Sponsor information
Industry
Worldwide Clinical Investigations—Oral
8700 Mason-Montgomery Road
Mason
45040
United States of America
| Phone | +49 (0)6173 302999 |
|---|---|
| mesples.u@pg.com | |
| Website | http://www.pg.com/en_US/ |
"ROR" |
https://ror.org/04dkns738 |
Funders
Funder type
Industry
Government organisation / For-profit companies (industry)
- Alternative name(s)
- Procter & Gamble, PandG, The Procter & Gamble Company, P&G
- Location
- United States of America
Results and Publications
| Intention to publish date | 31/10/2021 |
|---|---|
| Individual participant data (IPD) Intention to share | No |
| IPD sharing plan summary | Not expected to be made available |
| Publication and dissemination plan | Planned publication in a high-impact peer-reviewed journal. The study protocol, statistical analysis plan, and other additional documents are not intended to become available online. |
| IPD sharing plan | The datasets generated during and/or analysed during the current study are not expected to be made available because if the raw data is available but not analyzed appropriately by qualified experts in the area, it may lead to misinterpretation of the results. |
Editorial Notes
18/08/2020: Trial's existence confirmed by Ethics Committee of the State Medical Association Rhineland Palatinate.
